PRUNE2 and Familial prostate cancer: First, we present additional correlative evidence from two retrospective post-surgical primary prostate cancer cohorts in support of our experimental model of PCA3 as a dominant-negative oncogene and PRUNE2 as a tumor suppressor gene and for their co-regulation in human prostate cancer.